NAFLD-associated HCC: progress and opportunities
Due to an increase in the obesity-associated metabolic syndrome of epidemic proportions,
nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of hepatocellular …
nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of hepatocellular …
Phytochemicals as an alternative or integrative option, in conjunction with conventional treatments for hepatocellular carcinoma
S Rodriguez, K Skeet, T Mehmetoglu-Gurbuz… - Cancers, 2021 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is globally ranked as the sixth most
diagnosed cancer, and the second most deadly cancer. To worsen matters, there are only …
diagnosed cancer, and the second most deadly cancer. To worsen matters, there are only …
Robustness of radiomic features in CT images with different slice thickness, comparing liver tumour and muscle
Radiomic image features are becoming a promising non-invasive method to obtain
quantitative measurements for tumour classification and therapy response assessment in …
quantitative measurements for tumour classification and therapy response assessment in …
Tris (dibenzylideneacetone) dipalladium (0)(Tris DBA) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by …
L Arora, CD Mohan, MH Yang, S Rangappa… - Cancers, 2021 - mdpi.com
Simple Summary STAT3 is a major oncogenic transcription factor that is constitutively
activated in many types of human cancers, including hepatocellular carcinoma (HCC) and …
activated in many types of human cancers, including hepatocellular carcinoma (HCC) and …
Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis
Y Yu, L Bian, R Liu, Y Wang, X Xiao - Cancer cell international, 2021 - Springer
Background Circular RNA hsa_circ_0061395 (circ_0061395) has been reported to
accelerate the advancement of hepatocellular carcinoma (HCC). However, the regulatory …
accelerate the advancement of hepatocellular carcinoma (HCC). However, the regulatory …
On efficacy of microwave ablation in the thermal treatment of an early-stage hepatocellular carcinoma
Simple Summary Hepatocellular carcinoma accounts for around 75% of all liver cancers,
and represents the fourth most common cause of cancer-related deaths worldwide …
and represents the fourth most common cause of cancer-related deaths worldwide …
Predictors for the severe coronavirus disease 2019 (COVID-19) infection in patients with underlying liver disease: a retrospective analytical study in Iran
M Bahardoust, M Heiat, M Khodabandeh, A Karbasi… - Scientific Reports, 2021 - nature.com
Risk factors for clinical outcomes of COVID-19 pneumonia have not yet been well
established in patients with underlying liver diseases. Our study aimed to describe the …
established in patients with underlying liver diseases. Our study aimed to describe the …
[HTML][HTML] Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK …
J Hu, D Cai, Z Zhao, GC Zhong, J Gong - Frontiers in Oncology, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC), the most common malignant tumor, has high fatality and
recurrence rates. Accumulating evidence shows that heterogeneous nuclear …
recurrence rates. Accumulating evidence shows that heterogeneous nuclear …
Expression of cancer stem cell markers EpCAM and CD90 is correlated with anti-and pro-oncogenic EphA2 signaling in hepatocellular carcinoma
N Asakura, N Nakamura, A Muroi, Y Nojima… - International journal of …, 2021 - mdpi.com
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Additionally, the efficacy of targeted molecular therapies with multiple tyrosine kinase …
Additionally, the efficacy of targeted molecular therapies with multiple tyrosine kinase …
Deep learning based label-free small extracellular vesicles analyzer with light-sheet illumination differentiates normal and cancer liver cells
Z Wang, S Wang, G Chen, X Su - Sensors and Actuators B: Chemical, 2021 - Elsevier
Small extracellular vesicles (sEVs) are considered as potential markers for tumor detection
and vehicles for tumor treatment. Here we develop a deep learning based nanoparticle …
and vehicles for tumor treatment. Here we develop a deep learning based nanoparticle …